- Midostaurin, current overview and clinical experience of IHBT in 2021 - case reports2021 | First Faculty of Medicine
- Midostaurin - the First Targeted Therapy Drug for Patients with Acute Myeloid Leukaemia with FLT3 Mutation2022 | First Faculty of Medicine
- ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia2022 | Faculty of Pharmacy in Hradec Králové
- Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism2021 | Faculty of Pharmacy in Hradec Králové